Though the reauthorizations of the Prescription Drug User Fee Act (PDUFA VII) and the Biosimilar User Fee Act (BsUFA III) commits FDA to report quarterly hiring updates under the respective user fee programs, that data does not represent or capture the entirety of the Center for Drug Evaluation and Research’s (CDER’s) and the Center for Biologics Evaluation and Research (CBER’s) hiring progress or status.

In an effort to provide a more comprehensive overview of CDER’s and CBER’s hiring progress and status, FDA is providing these tables that display total hires which include what is reported under PDUFA VII and BsUFA III. FDA plans to update this table concurrently with the PDUFA and BsUFA quarterly hiring data page.

FY23 Quarterly Net Hiring for CDER (as of 6/17/2023)

* Numbers are based on data pulled on a particular date and could fluctuate slightly due to corrections in the underlying data if pulled on another day.
** External to CDER Gains and Losses
*** Each month/quarter is based on the last full pay period of the month. Q4 reflects through 09/30.

FY23 Quarterly Net Hiring for CBER (as of 06/17/2023)

* Numbers are based on data pulled on a particular date and could fluctuate slightly due to corrections in the underlying data if pulled on another day.
** External to CBER Gains and Losses
*** Each month/quarter is based on the last full pay period of the month. Q4 reflects through 09/30.